US President Joe Biden wants to lower costs and expand weight-loss medications to obese patients without other medical conditions. ING (the Internationale Nederlanden Groep) research says if President-elect Trump approves the proposal, it could increase consumer access and reduce household costs, impacting supply and long-term healthcare. The plan would cover an additional 7.5 million people from 2026 onwards — 3.5 million over 65 under Medicare and 4 million lower-income Americans under Medicaid.
